Extraction of the viral genomic RNA was performed using the automated platform NucliSens EasyMag (bioMérieux, Marcy l’Etoile, France) according to the manufacturer’s instructions. Quantification of total RNA was performed with the Qubit fluorimeter and the compatible Qubit RNA HS Assay (Thermo Fisher Scientific, Waltham, MA, USA). Amplicon-based NGS libraries were constructed using the QIAseq SARS-CoV-2 Primer Panel (Qiagen) quality-controlled using the Agilent High Sensitivity DNA assay for Bioanalyzer 2100 (Agilent Technologies), equimolarly mixed, and sequenced in a NextSeq 500 System (Illumina). The generated FASTQ files were aligned to the reference SARS-CoV-2 genome from Wuhan, China (GenBank Accession: NC_045512.2 , GISAID Accession: EPI_ISL_402123) with the Bowtie2 aligner (23 (link)) using the very-sensitive preset. Consensus FASTA sequences were exported from the generated BAM files using bcftools (24 (link)). Sequences were further filtered and those that were incomplete (sequence length < 29,000 nt) or had low coverage (entries with >5% Ns) were filtered out of the analysis.
Agilent high sensitivity dna assay for bioanalyzer 2100
Manufactured by Agilent Technologies
The Agilent High Sensitivity DNA assay is a lab equipment product designed for use with the Agilent Bioanalyzer 2100 system. The assay enables the analysis of DNA samples with high sensitivity, allowing for the detection and quantification of DNA fragments in the range of 50 to 7,000 base pairs.
Automatically generated - may contain errors
Lab products found in correlation
2 protocols using agilent high sensitivity dna assay for bioanalyzer 2100
1
SARS-CoV-2 Genome Sequencing Protocol
2
SARS-CoV-2 Genome Sequencing Protocol
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Extraction of the viral genomic RNA was performed using the automated platform NucliSens EasyMag (bioMérieux, Marcy l’Etoile, France) according to the manufacturer’s instructions. Quantification of total RNA was performed with the Qubit fluorimeter and the compatible Qubit RNA HS Assay (Thermo Fisher Scientific, Waltham, MA, USA). Amplicon-based NGS libraries were constructed using the QIAseq SARS-CoV-2 Primer Panel (Qiagen) quality-controlled using the Agilent High Sensitivity DNA assay for Bioanalyzer 2100 (Agilent Technologies), equimolarly mixed, and sequenced in a NextSeq 500 System (Illumina). The generated FASTQ files were aligned to the reference SARS-CoV-2 genome from Wuhan, China (GenBank Accession: NC_045512.2 , GISAID Accession: EPI_ISL_402123) with the Bowtie2 aligner (23 (link)) using the very-sensitive preset. Consensus FASTA sequences were exported from the generated BAM files using bcftools (24 (link)). Sequences were further filtered and those that were incomplete (sequence length < 29,000 nt) or had low coverage (entries with >5% Ns) were filtered out of the analysis.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!